Cargando…
Liver Fibrosis during Antiretroviral Treatment in HIV-Infected Individuals. Truth or Tale?
After the introduction of antiretroviral treatment (ART) back in 1996, the lifespan of people living with HIV (PLWH) has been substantially increased, while the major causes of morbidity and mortality have switched from opportunistic infections and AIDS-related neoplasms to cardiovascular and liver...
Autores principales: | Bakasis, Athanasios-Dimitrios, Androutsakos, Theodoros |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156893/ https://www.ncbi.nlm.nih.gov/pubmed/34063534 http://dx.doi.org/10.3390/cells10051212 |
Ejemplares similares
-
Liver Fibrosis in Primary Sjögren’s Syndrome
por: Androutsakos, Theodoros, et al.
Publicado: (2022) -
Antibody Responses after SARS-CoV-2 Vaccination in Patients with Liver Diseases
por: Bakasis, Athanasios-Dimitrios, et al.
Publicado: (2022) -
Causative factors of liver fibrosis in HIV-infected patients. A single center study
por: Androutsakos, Theodoros, et al.
Publicado: (2020) -
Single Nucleotide Polymorphisms of Toll-like Receptor 4 in Hepatocellular Carcinoma—A Single-Center Study
por: Androutsakos, Theodoros, et al.
Publicado: (2022) -
SGLT-2 Inhibitors in NAFLD: Expanding Their Role beyond Diabetes and Cardioprotection
por: Androutsakos, Theodoros, et al.
Publicado: (2022)